Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 4,412 shares at $191.46 ($846K) on 2025-10-28, disclosed to the SEC on 2025-10-29.
Scheduled sale ($846k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $192.32 | 1,008 | $194K | 22.9% |
| 2 | $192.32 | 1,008 | $194K | 22.9% |
| 3 | $191.46 | 1,198 | $229K | 27.1% |
| 4 | $191.46 | 1,198 | $229K | 27.1% |
| Total | $191.85 avg | 4,412 | $846K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |